Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
1.
J Mycol Med ; 32(4): 101312, 2022 Nov.
Article de Anglais | MEDLINE | ID: mdl-35914432

RÉSUMÉ

Gastro-intestinal mucormycosis (GIMM) is a highly lethal invasive fungal disease partly because of a challenging diagnosis. An allogeneic hematopoietic cell transplant recipient experienced bowel obstruction caused by slowly-evolutive gastro-intestinal mucormycosis and was successfully treated with surgery and antifungal therapy. Pathological findings revealed a granuloma without angio-invasion, which is unusual in this fungal disease and has incomplete similarities with an immune reconstitution inflammatory syndrome. Mucorales-specific PCR in both serum and resected tissue was positive and helped assessing the diagnosis. GIMM should be considered in front of unexplained granulomatosis or bowel obstruction in immunocompromised patients.


Sujet(s)
Transplantation de cellules souches hématopoïétiques , Infections fongiques invasives , Mucorales , Mucormycose , Humains , Mucormycose/diagnostic , Mucormycose/traitement médicamenteux , Transplantation de cellules souches hématopoïétiques/effets indésirables , Antifongiques/usage thérapeutique , Infections fongiques invasives/traitement médicamenteux , Sujet immunodéprimé
2.
Ann Surg ; 274(5): 773-779, 2021 11 01.
Article de Anglais | MEDLINE | ID: mdl-34342300

RÉSUMÉ

OBJECTIVE: The aim of this study was to evaluate the benefit of diverting enterostomy (DE) in patients with severe steroid-refractory (SR) gastrointestinal acute graft-versus-host-disease (GI-aGVHD) following allogeneic hematopoietic stem-cell transplantation (ASCT). SUMMARY AND BACKGROUND DATA: Severe GI-aGVHD refractory to the first-line steroid therapy is a rare but dramatic life-threatening complication. Second lines of immunosuppressors have limited effects and increase the risk of sepsis. Data suggest that limiting GI bacterial translocation by DE could restrain severe GI-aGVHD. METHODS: From 2004 to 2018, we retrospectively reviewed all consecutive patients undergoing ASCT for hematologic malignancies who developed severe SR GI-aGVHD. We compared patients in whom a proximal DE was performed (Enterostomy group) with those not subjected to DE (Medical group). The primary endpoint was the 1-year overall survival (OS) measured from the onset of GI-aGVHD. Secondary endpoints were the 2-year OS and causes of death. RESULTS: Of the 1295 patients who underwent ASCT, 51 patients with severe SR GI-aGVHD were analyzed (13 in Enterostomy group and 38 in Medical group). Characteristics of patients, transplantation modalities, and aGVHD severity were similar in both groups. The 1-year OS was better after DE (54% vs 5%, P = 0.0004). The 2-year OS was also better in "Enterostomy group" (31% vs 2.5%; P = 0.0015), with a trend to lower death by sepsis (30.8% vs 57.9%; P = 0.091). CONCLUSION: DE should be considered for severe GI-aGVHD as soon as resistance to the corticosteroid is identified.


Sujet(s)
Résistance aux substances , Entérostomie/méthodes , Maladies gastro-intestinales/chirurgie , Glucocorticoïdes/pharmacologie , Maladie du greffon contre l'hôte/chirurgie , Maladie aigüe , Adulte , Femelle , Études de suivi , France/épidémiologie , Maladies gastro-intestinales/diagnostic , Maladies gastro-intestinales/mortalité , Maladie du greffon contre l'hôte/diagnostic , Maladie du greffon contre l'hôte/mortalité , Tumeurs hématologiques/thérapie , Transplantation de cellules souches hématopoïétiques/effets indésirables , Humains , Mâle , Adulte d'âge moyen , Études prospectives , Indice de gravité de la maladie , Taux de survie/tendances
3.
J Gastrointest Surg ; 25(4): 1087-1088, 2021 04.
Article de Anglais | MEDLINE | ID: mdl-33237486

RÉSUMÉ

BACKGROUND: Intraductal papillary neoplasm of the bile duct (IPNB) or biliary papillomatosis is a precursor lesion of papillary cholangiocarcinoma.1 IPNB is recognized as a biliary counterpart of IPMN (pancreatic intraductal papillary mucinous neoplasm). IPNB is a rare disease involving entire (diffuse type) or one part (localized type) of biliary tree. Patients without distant metastasis are considered for surgical resection. For patients with distal bile duct papillomatosis, pancreaticoduodenectomy (PD) is recommended for patients with invasive distal bile duct IPNB. PD is a high complex procedure associated with the deterioration of endocrine and exocrine functions leading to a significant impact on quality of life.2 Some authors have reported a new surgical approach leading to a complete resection of the common bile duct without pancreatectomy.3 METHODS: We report the case of a 71-year-old female presented to our department with jaundice. At endoscopic ultrasound with cholangioscopy and CT scan, 2-cm distal bile duct mass tumor with villous component was seen. All needle biopsies were benign, and no distant disease was found. According to the risk of degeneration of this tumor, a surgical resection was decided. RESULTS: Intraoperative frozen section assessed the benignity of peripancreatic lymph nodes. We performed surgical ampullectomy with resection of the common bile duct. The intrapancreatic common bile duct was completely mobilized between the ampullectomy area and the upper edge of the pancreas. Frozen sections on distal and proximal margins of common bile duct were performed to discard malignancy. Finally, reconstruction consisted on the main pancreatic duct reimplantation to the duodenum and choledochoduodenostomy. The histological analysis confirmed the diagnosis of biliary papillomatosis with low-grade dysplasia. CONCLUSION: This procedure allows complete resection of benign tumors with endobiliary extension and preserve intestinal continuity and pancreatic parenchyma.


Sujet(s)
Tumeurs des canaux biliaires , Papillome , Sujet âgé , Tumeurs des canaux biliaires/imagerie diagnostique , Tumeurs des canaux biliaires/chirurgie , Conduits biliaires intrahépatiques , Conduit cholédoque/imagerie diagnostique , Conduit cholédoque/chirurgie , Femelle , Humains , Papillome/imagerie diagnostique , Papillome/chirurgie , Qualité de vie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE